Live Oak Investment Partners’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.65M Buy
8,806
+428
+5% +$78.7K 0.89% 31
2026
Q1
$1.58M Buy
8,378
+411
+5% +$86.6K 0.93% 26
2025
Q4
$1.58M Sell
7,967
-586
-7% -$118K 0.97% 30
2025
Q3
$1.74M Buy
8,553
+156
+2% +$27.7K 1.15% 26
2025
Q2
$1.48M Buy
+8,397
New +$1.26M 1.14% 26

Other funds holding THC

Live Oak Investment Partners's THC Position: Q2 2026 in Review

Live Oak Investment Partners increased its Tenet Healthcare (THC) stake by 5.1% in Q2 2026, buying an estimated $78.7K and bringing the position to 8,806 shares worth $1.65M. The position accounts for 0.89% of the portfolio, ranked #31.

Live Oak Investment Partners first reported a position in THC in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.74M in Q3 2025. 681 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Live Oak Investment Partners held 8,806 shares of Tenet Healthcare worth $1.65M as of Q2 2026.
  • Live Oak Investment Partners bought 428 Tenet Healthcare shares in Q2 2026, an estimated $78.7K.
  • Tenet Healthcare made up 0.89% of Live Oak Investment Partners's portfolio in Q2 2026, its #31 holding.
  • Live Oak Investment Partners first reported a position in Tenet Healthcare in Q2 2025 and has held it in 5 quarters since.
  • Live Oak Investment Partners's Tenet Healthcare position peaked at $1.74M in Q3 2025.
  • 681 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Live Oak Investment Partners's 13F filing for Q2 2026, filed 10 Aug 2026.